Interventional Neurology Device research

Interventional Neurology Device Comprehensive Study by Application (Oncology, Cardiology, Urology & Nephrology), Indication (Cerebral Aneurysms, Ischemic Stroke, Arteriovenous Malformations, Others), Device Types (Coiling and Embolization Devices (Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices), Angioplasty and Stenting Systems (Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)), Support Devices (Microcatheters, Guidewires), Neurothrombectomy Devices (Clot Retrieval Devices, Suction and Aspiration Devices, Snares)), End-Use (Hospitals, Ambulatory Surgical Centers, Neurology Clinics) Players and Region - Global Market Outlook to 2026

Interventional Neurology Device Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Interventional Neurology Device Market Scope?
Interventional neurology can hereby be defined as a specialty aimed towards treating some serious diseases of the brain, spine, as well as neck by the means of minimally invasive image-guided techniques. Some of the major diseases that are treated by interventional neurologists thereby include cerebral aneurysms, spinal vascular malformations, head and neck tumors, ischemic strokes, intracranial atherosclerosis, meningiomas, and vertebral body tumors. Intracranial aneurysm such as subarachnoid hemorrhage is one of the most common neurological conditions affecting over 30,000 people in the United States and over 2% of the world population each year. Central nervous system (AVM) arteriovenous malformations have been reported in over 0.15% of the US population, of which over 90% are supratentorial. Among these, over 4% of cerebral AVMs are due to hemorrhagic conversions. Interventional neurology uses various kinds of tools that pass through blood vessels so as to diagnose and treat diseases and conditions, rather than performing any kind of open surgery. These doctors use advanced radiological imaging and 3D technology to see and treat the part of the body for diagnosis and treatment.

The Interventional Neurology Device market study is being classified, by Application (Oncology, Cardiology and Urology & Nephrology) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Interventional Neurology Device market throughout the predicted period.

Stryker Corporation (United States), Johnson & Johnson (United States), Medtronic (Ireland), Terumo Corporation (Japan), Penumbra (United States), Microport (China), Abbott Laboratories (United States), W. L. Gore & Associates (United States), Merit Medical Systems, Inc. (United States), Boston Scientific Corporation (United States) and Cook Medical (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Interventional Neurology Device market by Type, Application and Region.

On the basis of geography, the market of Interventional Neurology Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Rising Demand for Effective Treatment Methods
  • A Surge in Demand for Minimally Invasive Procedures
  • Rising Patient Pool of Hemorrhagic and Ischemic Stroke

Market Drivers
  • High Incidence of Stroke and Brain Aneurysm
  • Increasing Demand for Interventional Neurology Devices
  • Growing Awareness among People
  • Growing Demand for Bare Platinum Coils

Opportunities
  • Strong Focus on Research & Development Leading To New Product Launches and Product Enhancement
  • Technological Advancements in the Field of Interventional Neurology

Restraints
  • A Dearth of Trained Interventional Neurologists
  • Stringent Regulatory Procedures

Challenges
  • High Cost of Procedures
  • The Lack of Well-Established Reimbursement Policies


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Interventional Neurology Device, Suppliers and Distributors of Interventional Neurology Device, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Oncology
  • Cardiology
  • Urology & Nephrology
By Indication
  • Cerebral Aneurysms
  • Ischemic Stroke
  • Arteriovenous Malformations
  • Others

By Device Types
  • Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices]
  • Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)]
  • Support Devices [Microcatheters, Guidewires]
  • Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares]

By End-Use
  • Hospitals
  • Ambulatory Surgical Centers
  • Neurology Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Incidence of Stroke and Brain Aneurysm
      • 3.2.2. Increasing Demand for Interventional Neurology Devices
      • 3.2.3. Growing Awareness among People
      • 3.2.4. Growing Demand for Bare Platinum Coils
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Procedures
      • 3.3.2. The Lack of Well-Established Reimbursement Policies
    • 3.4. Market Trends
      • 3.4.1. Rising Demand for Effective Treatment Methods
      • 3.4.2. A Surge in Demand for Minimally Invasive Procedures
      • 3.4.3. Rising Patient Pool of Hemorrhagic and Ischemic Stroke
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Interventional Neurology Device, by Application, Indication, Device Types, End-Use and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Interventional Neurology Device (Value)
      • 5.2.1. Global Interventional Neurology Device by: Application (Value)
        • 5.2.1.1. Oncology
        • 5.2.1.2. Cardiology
        • 5.2.1.3. Urology & Nephrology
      • 5.2.2. Global Interventional Neurology Device by: Indication (Value)
        • 5.2.2.1. Cerebral Aneurysms
        • 5.2.2.2. Ischemic Stroke
        • 5.2.2.3. Arteriovenous Malformations
        • 5.2.2.4. Others
      • 5.2.3. Global Interventional Neurology Device by: Device Types (Value)
        • 5.2.3.1. Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices]
        • 5.2.3.2. Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)]
        • 5.2.3.3. Support Devices [Microcatheters, Guidewires]
        • 5.2.3.4. Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares]
      • 5.2.4. Global Interventional Neurology Device by: End-Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Ambulatory Surgical Centers
        • 5.2.4.3. Neurology Clinics
      • 5.2.5. Global Interventional Neurology Device Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Interventional Neurology Device (Volume)
      • 5.3.1. Global Interventional Neurology Device by: Application (Volume)
        • 5.3.1.1. Oncology
        • 5.3.1.2. Cardiology
        • 5.3.1.3. Urology & Nephrology
      • 5.3.2. Global Interventional Neurology Device by: Indication (Volume)
        • 5.3.2.1. Cerebral Aneurysms
        • 5.3.2.2. Ischemic Stroke
        • 5.3.2.3. Arteriovenous Malformations
        • 5.3.2.4. Others
      • 5.3.3. Global Interventional Neurology Device by: Device Types (Volume)
        • 5.3.3.1. Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices]
        • 5.3.3.2. Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)]
        • 5.3.3.3. Support Devices [Microcatheters, Guidewires]
        • 5.3.3.4. Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares]
      • 5.3.4. Global Interventional Neurology Device by: End-Use (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Ambulatory Surgical Centers
        • 5.3.4.3. Neurology Clinics
      • 5.3.5. Global Interventional Neurology Device Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Interventional Neurology Device (Price)
  • 6. Interventional Neurology Device: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Stryker Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Terumo Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Penumbra (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Microport (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Abbott Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. W. L. Gore & Associates (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merit Medical Systems, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Boston Scientific Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Cook Medical (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Interventional Neurology Device Sale, by Application, Indication, Device Types, End-Use and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Interventional Neurology Device (Value)
      • 7.2.1. Global Interventional Neurology Device by: Application (Value)
        • 7.2.1.1. Oncology
        • 7.2.1.2. Cardiology
        • 7.2.1.3. Urology & Nephrology
      • 7.2.2. Global Interventional Neurology Device by: Indication (Value)
        • 7.2.2.1. Cerebral Aneurysms
        • 7.2.2.2. Ischemic Stroke
        • 7.2.2.3. Arteriovenous Malformations
        • 7.2.2.4. Others
      • 7.2.3. Global Interventional Neurology Device by: Device Types (Value)
        • 7.2.3.1. Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices]
        • 7.2.3.2. Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)]
        • 7.2.3.3. Support Devices [Microcatheters, Guidewires]
        • 7.2.3.4. Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares]
      • 7.2.4. Global Interventional Neurology Device by: End-Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Ambulatory Surgical Centers
        • 7.2.4.3. Neurology Clinics
      • 7.2.5. Global Interventional Neurology Device Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Interventional Neurology Device (Volume)
      • 7.3.1. Global Interventional Neurology Device by: Application (Volume)
        • 7.3.1.1. Oncology
        • 7.3.1.2. Cardiology
        • 7.3.1.3. Urology & Nephrology
      • 7.3.2. Global Interventional Neurology Device by: Indication (Volume)
        • 7.3.2.1. Cerebral Aneurysms
        • 7.3.2.2. Ischemic Stroke
        • 7.3.2.3. Arteriovenous Malformations
        • 7.3.2.4. Others
      • 7.3.3. Global Interventional Neurology Device by: Device Types (Volume)
        • 7.3.3.1. Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices]
        • 7.3.3.2. Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)]
        • 7.3.3.3. Support Devices [Microcatheters, Guidewires]
        • 7.3.3.4. Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares]
      • 7.3.4. Global Interventional Neurology Device by: End-Use (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Ambulatory Surgical Centers
        • 7.3.4.3. Neurology Clinics
      • 7.3.5. Global Interventional Neurology Device Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Interventional Neurology Device (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Interventional Neurology Device: by Application(USD Million)
  • Table 2. Interventional Neurology Device Oncology , by Region USD Million (2015-2020)
  • Table 3. Interventional Neurology Device Cardiology , by Region USD Million (2015-2020)
  • Table 4. Interventional Neurology Device Urology & Nephrology , by Region USD Million (2015-2020)
  • Table 5. Interventional Neurology Device: by Indication(USD Million)
  • Table 6. Interventional Neurology Device Cerebral Aneurysms , by Region USD Million (2015-2020)
  • Table 7. Interventional Neurology Device Ischemic Stroke , by Region USD Million (2015-2020)
  • Table 8. Interventional Neurology Device Arteriovenous Malformations , by Region USD Million (2015-2020)
  • Table 9. Interventional Neurology Device Others , by Region USD Million (2015-2020)
  • Table 10. Interventional Neurology Device: by Device Types(USD Million)
  • Table 11. Interventional Neurology Device Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices] , by Region USD Million (2015-2020)
  • Table 12. Interventional Neurology Device Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)] , by Region USD Million (2015-2020)
  • Table 13. Interventional Neurology Device Support Devices [Microcatheters, Guidewires] , by Region USD Million (2015-2020)
  • Table 14. Interventional Neurology Device Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares] , by Region USD Million (2015-2020)
  • Table 15. Interventional Neurology Device: by End-Use(USD Million)
  • Table 16. Interventional Neurology Device Hospitals , by Region USD Million (2015-2020)
  • Table 17. Interventional Neurology Device Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 18. Interventional Neurology Device Neurology Clinics , by Region USD Million (2015-2020)
  • Table 19. South America Interventional Neurology Device, by Country USD Million (2015-2020)
  • Table 20. South America Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 21. South America Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 22. South America Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 23. South America Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 24. Brazil Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 25. Brazil Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 26. Brazil Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 27. Brazil Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 28. Argentina Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 29. Argentina Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 30. Argentina Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 31. Argentina Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 32. Rest of South America Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 33. Rest of South America Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 34. Rest of South America Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 35. Rest of South America Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 36. Asia Pacific Interventional Neurology Device, by Country USD Million (2015-2020)
  • Table 37. Asia Pacific Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 38. Asia Pacific Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 39. Asia Pacific Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 40. Asia Pacific Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 41. China Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 42. China Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 43. China Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 44. China Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 45. Japan Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 46. Japan Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 47. Japan Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 48. Japan Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 49. India Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 50. India Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 51. India Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 52. India Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 53. South Korea Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 54. South Korea Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 55. South Korea Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 56. South Korea Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 57. Taiwan Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 58. Taiwan Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 59. Taiwan Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 60. Taiwan Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 61. Australia Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 62. Australia Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 63. Australia Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 64. Australia Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 69. Europe Interventional Neurology Device, by Country USD Million (2015-2020)
  • Table 70. Europe Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 71. Europe Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 72. Europe Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 73. Europe Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 74. Germany Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 75. Germany Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 76. Germany Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 77. Germany Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 78. France Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 79. France Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 80. France Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 81. France Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 82. Italy Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 83. Italy Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 84. Italy Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 85. Italy Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 86. United Kingdom Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 87. United Kingdom Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 88. United Kingdom Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 89. United Kingdom Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 90. Netherlands Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 91. Netherlands Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 92. Netherlands Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 93. Netherlands Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 94. Rest of Europe Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 95. Rest of Europe Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 96. Rest of Europe Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 97. Rest of Europe Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 98. MEA Interventional Neurology Device, by Country USD Million (2015-2020)
  • Table 99. MEA Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 100. MEA Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 101. MEA Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 102. MEA Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 103. Middle East Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 104. Middle East Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 105. Middle East Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 106. Middle East Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 107. Africa Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 108. Africa Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 109. Africa Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 110. Africa Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 111. North America Interventional Neurology Device, by Country USD Million (2015-2020)
  • Table 112. North America Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 113. North America Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 114. North America Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 115. North America Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 116. United States Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 117. United States Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 118. United States Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 119. United States Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 120. Canada Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 121. Canada Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 122. Canada Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 123. Canada Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 124. Mexico Interventional Neurology Device, by Application USD Million (2015-2020)
  • Table 125. Mexico Interventional Neurology Device, by Indication USD Million (2015-2020)
  • Table 126. Mexico Interventional Neurology Device, by Device Types USD Million (2015-2020)
  • Table 127. Mexico Interventional Neurology Device, by End-Use USD Million (2015-2020)
  • Table 128. Interventional Neurology Device Sales: by Application(K Units)
  • Table 129. Interventional Neurology Device Sales Oncology , by Region K Units (2015-2020)
  • Table 130. Interventional Neurology Device Sales Cardiology , by Region K Units (2015-2020)
  • Table 131. Interventional Neurology Device Sales Urology & Nephrology , by Region K Units (2015-2020)
  • Table 132. Interventional Neurology Device Sales: by Indication(K Units)
  • Table 133. Interventional Neurology Device Sales Cerebral Aneurysms , by Region K Units (2015-2020)
  • Table 134. Interventional Neurology Device Sales Ischemic Stroke , by Region K Units (2015-2020)
  • Table 135. Interventional Neurology Device Sales Arteriovenous Malformations , by Region K Units (2015-2020)
  • Table 136. Interventional Neurology Device Sales Others , by Region K Units (2015-2020)
  • Table 137. Interventional Neurology Device Sales: by Device Types(K Units)
  • Table 138. Interventional Neurology Device Sales Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices] , by Region K Units (2015-2020)
  • Table 139. Interventional Neurology Device Sales Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)] , by Region K Units (2015-2020)
  • Table 140. Interventional Neurology Device Sales Support Devices [Microcatheters, Guidewires] , by Region K Units (2015-2020)
  • Table 141. Interventional Neurology Device Sales Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares] , by Region K Units (2015-2020)
  • Table 142. Interventional Neurology Device Sales: by End-Use(K Units)
  • Table 143. Interventional Neurology Device Sales Hospitals , by Region K Units (2015-2020)
  • Table 144. Interventional Neurology Device Sales Ambulatory Surgical Centers , by Region K Units (2015-2020)
  • Table 145. Interventional Neurology Device Sales Neurology Clinics , by Region K Units (2015-2020)
  • Table 146. South America Interventional Neurology Device Sales, by Country K Units (2015-2020)
  • Table 147. South America Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 148. South America Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 149. South America Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 150. South America Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 151. Brazil Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 152. Brazil Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 153. Brazil Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 154. Brazil Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 155. Argentina Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 156. Argentina Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 157. Argentina Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 158. Argentina Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 159. Rest of South America Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 160. Rest of South America Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 161. Rest of South America Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 162. Rest of South America Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 163. Asia Pacific Interventional Neurology Device Sales, by Country K Units (2015-2020)
  • Table 164. Asia Pacific Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 165. Asia Pacific Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 166. Asia Pacific Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 167. Asia Pacific Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 168. China Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 169. China Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 170. China Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 171. China Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 172. Japan Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 173. Japan Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 174. Japan Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 175. Japan Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 176. India Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 177. India Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 178. India Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 179. India Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 180. South Korea Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 181. South Korea Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 182. South Korea Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 183. South Korea Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 184. Taiwan Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 185. Taiwan Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 186. Taiwan Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 187. Taiwan Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 188. Australia Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 189. Australia Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 190. Australia Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 191. Australia Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 192. Rest of Asia-Pacific Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 193. Rest of Asia-Pacific Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 194. Rest of Asia-Pacific Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 195. Rest of Asia-Pacific Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 196. Europe Interventional Neurology Device Sales, by Country K Units (2015-2020)
  • Table 197. Europe Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 198. Europe Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 199. Europe Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 200. Europe Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 201. Germany Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 202. Germany Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 203. Germany Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 204. Germany Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 205. France Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 206. France Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 207. France Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 208. France Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 209. Italy Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 210. Italy Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 211. Italy Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 212. Italy Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 213. United Kingdom Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 214. United Kingdom Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 215. United Kingdom Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 216. United Kingdom Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 217. Netherlands Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 218. Netherlands Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 219. Netherlands Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 220. Netherlands Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 221. Rest of Europe Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 222. Rest of Europe Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 223. Rest of Europe Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 224. Rest of Europe Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 225. MEA Interventional Neurology Device Sales, by Country K Units (2015-2020)
  • Table 226. MEA Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 227. MEA Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 228. MEA Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 229. MEA Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 230. Middle East Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 231. Middle East Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 232. Middle East Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 233. Middle East Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 234. Africa Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 235. Africa Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 236. Africa Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 237. Africa Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 238. North America Interventional Neurology Device Sales, by Country K Units (2015-2020)
  • Table 239. North America Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 240. North America Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 241. North America Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 242. North America Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 243. United States Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 244. United States Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 245. United States Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 246. United States Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 247. Canada Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 248. Canada Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 249. Canada Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 250. Canada Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 251. Mexico Interventional Neurology Device Sales, by Application K Units (2015-2020)
  • Table 252. Mexico Interventional Neurology Device Sales, by Indication K Units (2015-2020)
  • Table 253. Mexico Interventional Neurology Device Sales, by Device Types K Units (2015-2020)
  • Table 254. Mexico Interventional Neurology Device Sales, by End-Use K Units (2015-2020)
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Interventional Neurology Device: by Application(USD Million)
  • Table 267. Interventional Neurology Device Oncology , by Region USD Million (2021-2026)
  • Table 268. Interventional Neurology Device Cardiology , by Region USD Million (2021-2026)
  • Table 269. Interventional Neurology Device Urology & Nephrology , by Region USD Million (2021-2026)
  • Table 270. Interventional Neurology Device: by Indication(USD Million)
  • Table 271. Interventional Neurology Device Cerebral Aneurysms , by Region USD Million (2021-2026)
  • Table 272. Interventional Neurology Device Ischemic Stroke , by Region USD Million (2021-2026)
  • Table 273. Interventional Neurology Device Arteriovenous Malformations , by Region USD Million (2021-2026)
  • Table 274. Interventional Neurology Device Others , by Region USD Million (2021-2026)
  • Table 275. Interventional Neurology Device: by Device Types(USD Million)
  • Table 276. Interventional Neurology Device Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices] , by Region USD Million (2021-2026)
  • Table 277. Interventional Neurology Device Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)] , by Region USD Million (2021-2026)
  • Table 278. Interventional Neurology Device Support Devices [Microcatheters, Guidewires] , by Region USD Million (2021-2026)
  • Table 279. Interventional Neurology Device Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares] , by Region USD Million (2021-2026)
  • Table 280. Interventional Neurology Device: by End-Use(USD Million)
  • Table 281. Interventional Neurology Device Hospitals , by Region USD Million (2021-2026)
  • Table 282. Interventional Neurology Device Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 283. Interventional Neurology Device Neurology Clinics , by Region USD Million (2021-2026)
  • Table 284. South America Interventional Neurology Device, by Country USD Million (2021-2026)
  • Table 285. South America Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 286. South America Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 287. South America Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 288. South America Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 289. Brazil Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 290. Brazil Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 291. Brazil Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 292. Brazil Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 293. Argentina Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 294. Argentina Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 295. Argentina Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 296. Argentina Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 297. Rest of South America Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 298. Rest of South America Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 299. Rest of South America Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 300. Rest of South America Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 301. Asia Pacific Interventional Neurology Device, by Country USD Million (2021-2026)
  • Table 302. Asia Pacific Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 303. Asia Pacific Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 304. Asia Pacific Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 305. Asia Pacific Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 306. China Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 307. China Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 308. China Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 309. China Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 310. Japan Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 311. Japan Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 312. Japan Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 313. Japan Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 314. India Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 315. India Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 316. India Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 317. India Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 318. South Korea Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 319. South Korea Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 320. South Korea Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 321. South Korea Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 322. Taiwan Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 323. Taiwan Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 324. Taiwan Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 325. Taiwan Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 326. Australia Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 327. Australia Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 328. Australia Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 329. Australia Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 330. Rest of Asia-Pacific Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 331. Rest of Asia-Pacific Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 332. Rest of Asia-Pacific Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 333. Rest of Asia-Pacific Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 334. Europe Interventional Neurology Device, by Country USD Million (2021-2026)
  • Table 335. Europe Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 336. Europe Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 337. Europe Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 338. Europe Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 339. Germany Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 340. Germany Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 341. Germany Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 342. Germany Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 343. France Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 344. France Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 345. France Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 346. France Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 347. Italy Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 348. Italy Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 349. Italy Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 350. Italy Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 351. United Kingdom Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 352. United Kingdom Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 353. United Kingdom Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 354. United Kingdom Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 355. Netherlands Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 356. Netherlands Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 357. Netherlands Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 358. Netherlands Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 359. Rest of Europe Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 360. Rest of Europe Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 361. Rest of Europe Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 362. Rest of Europe Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 363. MEA Interventional Neurology Device, by Country USD Million (2021-2026)
  • Table 364. MEA Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 365. MEA Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 366. MEA Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 367. MEA Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 368. Middle East Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 369. Middle East Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 370. Middle East Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 371. Middle East Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 372. Africa Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 373. Africa Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 374. Africa Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 375. Africa Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 376. North America Interventional Neurology Device, by Country USD Million (2021-2026)
  • Table 377. North America Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 378. North America Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 379. North America Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 380. North America Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 381. United States Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 382. United States Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 383. United States Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 384. United States Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 385. Canada Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 386. Canada Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 387. Canada Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 388. Canada Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 389. Mexico Interventional Neurology Device, by Application USD Million (2021-2026)
  • Table 390. Mexico Interventional Neurology Device, by Indication USD Million (2021-2026)
  • Table 391. Mexico Interventional Neurology Device, by Device Types USD Million (2021-2026)
  • Table 392. Mexico Interventional Neurology Device, by End-Use USD Million (2021-2026)
  • Table 393. Interventional Neurology Device Sales: by Application(K Units)
  • Table 394. Interventional Neurology Device Sales Oncology , by Region K Units (2021-2026)
  • Table 395. Interventional Neurology Device Sales Cardiology , by Region K Units (2021-2026)
  • Table 396. Interventional Neurology Device Sales Urology & Nephrology , by Region K Units (2021-2026)
  • Table 397. Interventional Neurology Device Sales: by Indication(K Units)
  • Table 398. Interventional Neurology Device Sales Cerebral Aneurysms , by Region K Units (2021-2026)
  • Table 399. Interventional Neurology Device Sales Ischemic Stroke , by Region K Units (2021-2026)
  • Table 400. Interventional Neurology Device Sales Arteriovenous Malformations , by Region K Units (2021-2026)
  • Table 401. Interventional Neurology Device Sales Others , by Region K Units (2021-2026)
  • Table 402. Interventional Neurology Device Sales: by Device Types(K Units)
  • Table 403. Interventional Neurology Device Sales Coiling and Embolization Devices [Embolic Coils (Bare Detachable Coils, Coated Detachable Coils), Liquid Embolic Agents, Flow Diverting Devices] , by Region K Units (2021-2026)
  • Table 404. Interventional Neurology Device Sales Angioplasty and Stenting Systems [Carotid Artery Stents, Embolic Protection Systems (Distal Filter Devices, Balloon Occlusion Devices)] , by Region K Units (2021-2026)
  • Table 405. Interventional Neurology Device Sales Support Devices [Microcatheters, Guidewires] , by Region K Units (2021-2026)
  • Table 406. Interventional Neurology Device Sales Neurothrombectomy Devices [Clot Retrieval Devices, Suction and Aspiration Devices, Snares] , by Region K Units (2021-2026)
  • Table 407. Interventional Neurology Device Sales: by End-Use(K Units)
  • Table 408. Interventional Neurology Device Sales Hospitals , by Region K Units (2021-2026)
  • Table 409. Interventional Neurology Device Sales Ambulatory Surgical Centers , by Region K Units (2021-2026)
  • Table 410. Interventional Neurology Device Sales Neurology Clinics , by Region K Units (2021-2026)
  • Table 411. South America Interventional Neurology Device Sales, by Country K Units (2021-2026)
  • Table 412. South America Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 413. South America Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 414. South America Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 415. South America Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 416. Brazil Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 417. Brazil Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 418. Brazil Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 419. Brazil Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 420. Argentina Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 421. Argentina Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 422. Argentina Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 423. Argentina Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 424. Rest of South America Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 425. Rest of South America Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 426. Rest of South America Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 427. Rest of South America Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 428. Asia Pacific Interventional Neurology Device Sales, by Country K Units (2021-2026)
  • Table 429. Asia Pacific Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 430. Asia Pacific Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 431. Asia Pacific Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 432. Asia Pacific Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 433. China Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 434. China Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 435. China Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 436. China Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 437. Japan Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 438. Japan Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 439. Japan Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 440. Japan Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 441. India Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 442. India Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 443. India Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 444. India Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 445. South Korea Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 446. South Korea Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 447. South Korea Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 448. South Korea Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 449. Taiwan Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 450. Taiwan Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 451. Taiwan Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 452. Taiwan Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 453. Australia Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 454. Australia Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 455. Australia Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 456. Australia Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 457. Rest of Asia-Pacific Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 458. Rest of Asia-Pacific Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 459. Rest of Asia-Pacific Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 460. Rest of Asia-Pacific Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 461. Europe Interventional Neurology Device Sales, by Country K Units (2021-2026)
  • Table 462. Europe Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 463. Europe Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 464. Europe Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 465. Europe Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 466. Germany Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 467. Germany Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 468. Germany Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 469. Germany Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 470. France Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 471. France Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 472. France Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 473. France Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 474. Italy Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 475. Italy Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 476. Italy Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 477. Italy Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 478. United Kingdom Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 479. United Kingdom Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 480. United Kingdom Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 481. United Kingdom Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 482. Netherlands Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 483. Netherlands Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 484. Netherlands Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 485. Netherlands Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 486. Rest of Europe Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 487. Rest of Europe Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 488. Rest of Europe Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 489. Rest of Europe Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 490. MEA Interventional Neurology Device Sales, by Country K Units (2021-2026)
  • Table 491. MEA Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 492. MEA Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 493. MEA Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 494. MEA Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 495. Middle East Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 496. Middle East Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 497. Middle East Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 498. Middle East Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 499. Africa Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 500. Africa Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 501. Africa Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 502. Africa Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 503. North America Interventional Neurology Device Sales, by Country K Units (2021-2026)
  • Table 504. North America Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 505. North America Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 506. North America Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 507. North America Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 508. United States Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 509. United States Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 510. United States Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 511. United States Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 512. Canada Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 513. Canada Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 514. Canada Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 515. Canada Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 516. Mexico Interventional Neurology Device Sales, by Application K Units (2021-2026)
  • Table 517. Mexico Interventional Neurology Device Sales, by Indication K Units (2021-2026)
  • Table 518. Mexico Interventional Neurology Device Sales, by Device Types K Units (2021-2026)
  • Table 519. Mexico Interventional Neurology Device Sales, by End-Use K Units (2021-2026)
  • Table 520. Research Programs/Design for This Report
  • Table 521. Key Data Information from Secondary Sources
  • Table 522. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Interventional Neurology Device: by Application USD Million (2015-2020)
  • Figure 5. Global Interventional Neurology Device: by Indication USD Million (2015-2020)
  • Figure 6. Global Interventional Neurology Device: by Device Types USD Million (2015-2020)
  • Figure 7. Global Interventional Neurology Device: by End-Use USD Million (2015-2020)
  • Figure 8. South America Interventional Neurology Device Share (%), by Country
  • Figure 9. Asia Pacific Interventional Neurology Device Share (%), by Country
  • Figure 10. Europe Interventional Neurology Device Share (%), by Country
  • Figure 11. MEA Interventional Neurology Device Share (%), by Country
  • Figure 12. North America Interventional Neurology Device Share (%), by Country
  • Figure 13. Global Interventional Neurology Device: by Application K Units (2015-2020)
  • Figure 14. Global Interventional Neurology Device: by Indication K Units (2015-2020)
  • Figure 15. Global Interventional Neurology Device: by Device Types K Units (2015-2020)
  • Figure 16. Global Interventional Neurology Device: by End-Use K Units (2015-2020)
  • Figure 17. South America Interventional Neurology Device Share (%), by Country
  • Figure 18. Asia Pacific Interventional Neurology Device Share (%), by Country
  • Figure 19. Europe Interventional Neurology Device Share (%), by Country
  • Figure 20. MEA Interventional Neurology Device Share (%), by Country
  • Figure 21. North America Interventional Neurology Device Share (%), by Country
  • Figure 22. Global Interventional Neurology Device share by Players 2020 (%)
  • Figure 23. Global Interventional Neurology Device share by Players (Top 3) 2020(%)
  • Figure 24. Global Interventional Neurology Device share by Players (Top 5) 2020(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Stryker Corporation (United States) Revenue: by Geography 2020
  • Figure 28. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 29. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 30. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 31. Medtronic (Ireland) Revenue: by Geography 2020
  • Figure 32. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Terumo Corporation (Japan) Revenue: by Geography 2020
  • Figure 34. Penumbra (United States) Revenue, Net Income and Gross profit
  • Figure 35. Penumbra (United States) Revenue: by Geography 2020
  • Figure 36. Microport (China) Revenue, Net Income and Gross profit
  • Figure 37. Microport (China) Revenue: by Geography 2020
  • Figure 38. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 39. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 40. W. L. Gore & Associates (United States) Revenue, Net Income and Gross profit
  • Figure 41. W. L. Gore & Associates (United States) Revenue: by Geography 2020
  • Figure 42. Merit Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 43. Merit Medical Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 44. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 45. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 46. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 47. Cook Medical (United States) Revenue: by Geography 2020
  • Figure 48. Global Interventional Neurology Device: by Application USD Million (2021-2026)
  • Figure 49. Global Interventional Neurology Device: by Indication USD Million (2021-2026)
  • Figure 50. Global Interventional Neurology Device: by Device Types USD Million (2021-2026)
  • Figure 51. Global Interventional Neurology Device: by End-Use USD Million (2021-2026)
  • Figure 52. South America Interventional Neurology Device Share (%), by Country
  • Figure 53. Asia Pacific Interventional Neurology Device Share (%), by Country
  • Figure 54. Europe Interventional Neurology Device Share (%), by Country
  • Figure 55. MEA Interventional Neurology Device Share (%), by Country
  • Figure 56. North America Interventional Neurology Device Share (%), by Country
  • Figure 57. Global Interventional Neurology Device: by Application K Units (2021-2026)
  • Figure 58. Global Interventional Neurology Device: by Indication K Units (2021-2026)
  • Figure 59. Global Interventional Neurology Device: by Device Types K Units (2021-2026)
  • Figure 60. Global Interventional Neurology Device: by End-Use K Units (2021-2026)
  • Figure 61. South America Interventional Neurology Device Share (%), by Country
  • Figure 62. Asia Pacific Interventional Neurology Device Share (%), by Country
  • Figure 63. Europe Interventional Neurology Device Share (%), by Country
  • Figure 64. MEA Interventional Neurology Device Share (%), by Country
  • Figure 65. North America Interventional Neurology Device Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Stryker Corporation (United States)
  • Johnson & Johnson (United States)
  • Medtronic (Ireland)
  • Terumo Corporation (Japan)
  • Penumbra (United States)
  • Microport (China)
  • Abbott Laboratories (United States)
  • W. L. Gore & Associates (United States)
  • Merit Medical Systems, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Cook Medical (United States)
Select User Access Type

Key Highlights of Report


Mar 2021 246 Pages 68 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Interventional Neurology Device research Quantitative research analysis
Interventional Neurology Device research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Interventional Neurology Device research Report?

Have a Query? Click Here

Other Related Reports

Ear Speculum Comprehensive Study by Type (Plastic, Stainless Steel, Others), Application (Surgery, Examination, Others), Usage (Disposable, Non-Disposable), Size (0.5 to 3mm, 4 to 6 mm, Above 7mm) Pl...
$ 3500
Intraoral Scanners Comprehensive Study by Type (Standalone Intraoral Scanners, Portable Intraoral Scanners), End User (Hospitals, Dental Clinics, Others) Players and Region - Global Market Outlook to...
$ 3500
Medical Silicone Comprehensive Study by Type (Liquid Silicone Rubber, High Consistency Rubber, Fluorosilicone Rubber, Room Temperature Vulcanize Silicone), Application (Prosthetics (limbs & implants)...
$ 3650
Bandage Roll Comprehensive Study by Type (Sterile Bandage, Non-Sterile Bandage), Application (Hospital & Clinical, Home Care, Other), Bandage Roll Type (General, Waterproof), Use (Wound Dressing, Sur...
$ 3450
Grooming Table Comprehensive Study by Type (Electric, Hydraulic, Manual, Other), Application (Pet Hospital, Veterinary Station, Other) Players and Region - Global Market Outlook to 2030
$ 3500
Monitoring Electrodes Comprehensive Study by Type (Solid Gel Electrode, Foam Electrode, Others), Application (Hospitals And Clinics, Bioscience Research Institutions, Others) Players and Region - Glo...
$ 3500